Success Stories: Thanks to Our Experts, O1-A Approval Made Possible in Just 2 Months and 11 Days for a Formulations Investigator from Pakistan with Over 1,800 Citations


Client’s Testimonial:

“Please accept my sincere thanks for the excellent support provided by you and your staff to procure I-129 O1A petition approval. Your efforts contributed substantially to the quality of the petition and the effectiveness of the extraordinary capability was enhanced by the professionalism displayed by your staff in providing the right directions, support, and logistics. Thank you for your gracious guidance and professionalism.”

On May 2nd, 2022, we received another O1-A (Individuals with Extraordinary Ability or Achievement) approval for a Formulations Investigator in the Field of Pharmaceutical Technology (Approval Notice).

General Field: Pharmaceutical Technology

Position at the Time of Case Filing: Formulations Investigator

Country of Origin: Pakistan

State of Residence at the Time of Filing: Montana

Approval Notice Date: May 2nd, 2022

Processing Time: 2 months, 11 days (Premium Processing Requested)

Case Summary:

The O1-A or Individual of Extraordinary Ability is for those individuals who possess extraordinary ability in the sciences, arts, education, business, or athletics, or who have a demonstrated record of extraordinary achievement in the motion picture or television industry and have been recognized nationally or internationally for those achievements. So when a formulation investigator in pharmaceutical technology came to us from Pakistan, we ensured the success of her case by making a list of her strong points. The following is the list of items we gathered from her CVs, certificates, transcripts, letters of recommendation, etc.:

  • As an expert in the field of pharmaceutical technology, her proposed endeavor is to continue developing techniques for programmed site-specific drug delivery and stimuli-responsive nanoparticulate drug formulations. She wants to improve the treatment of cancer, lung disease, and antimicrobial-resistant infectious diseases.
  • Her research is of great importance because it provides the field with targeted strategies for treating cancer, lung disease, and antimicrobial-resistant infectious diseases. This is particularly important considering the immense threat that drug resistance poses to global health. It leads to prolonged illnesses, which elongate hospital stays, increase death and disability, and exacerbate medical expenses.
  • More specifically, her proposed endeavor also has broad implications for the United States. Of the many diseases she has helped to improve the treatment of, is cancer, which has an immense societal and economic impact in the U.S.
  • At the same time, her work has gained popularity due to which she has been regularly invited to conduct peer reviews for authoritative journals in the field, and has completed at least 30 reviews to date.
  • Her research has resulted in 66 peer-reviewed journal articles (5 of them first-authored) and 3 book chapters (1 of them first-authored) which have been cited a huge total of 1,842 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of pharmaceutical technology.
  • She has thus authored at least 15 papers that rank among the top 10% most-cited articles across the entire field of pharmacology & toxicology for their respective years of publication.
  • Finally, her study was funded by the European Commission’s ALEXANDER Project, which sponsors the research and development of MPP drug systems, and she was also the recipient of a prestigious international award for women in science.
  • Her 11 years of work have given her a hold over the area and she has gathered supporters from all over the world. She was able to obtain 4 letters of recommendation from experts who knew her work and one of them said:

“[The client’s] research has resulted in mucus-penetrating drugs with higher levels of mucoadhesiveness, addressing this common shortcoming and helping the United States to maintain its dominance in the biopharmaceutical industry. In sum, based on her myriad successes thus far, it is my professional opinion that the United States would be remiss if it did not provide [the client] with a platform for her future work.”

So, her O1-A case was approved without an RFE, thanks to our team of excellent experts who prepared her petition packet.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.